Answers are grounded in this paper and cite their sources.
Thin, flexible packaging of integrated circuits (ICs) is essential for next-generation implantable devices, where extreme miniaturisation must be achieved without compromising reliability. This work presents a fabrication process for ultrathin chip packages based on liquid crystal polymer (LCP), selected for its biocompatibility, chemical stability, and barrier properties. Dies thinned to 30 μ m were embedded into laser-skived cavities within a high- and low-temperature LCP stack using vacuum lamination. Electrical access was achieved using a hybrid picosecond-laser and reactive ion etching (RIE) via process, followed by metallisation and fan-out patterning. The approach was validated using PTCE daisy-chain structures and MSP430 microcontrollers. Across 11.704 vias, all were electrically functional with negligible resistance contribution. Of 16 encapsulated MSP430 devices, 62.5% remained programmable. Assembly on flexible substrates yielded high pad-level connectivity (96.8% PTCE, 99.1% MSP430) and 75% functional yield. Full LCP encapsulation was demonstrated as a proof of concept, confirming the feasibility of this scalable ultrathin packaging approach.
No takes yet. Share an insight, caveat, or question.
Lasure et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: